In AD patients, NGF level is markedly higher in cerebrospinal fluid (CSF), and cholinergic neuron target areas such as the hippocampus and cortex (Hock et al., 2000; Fahnestock et al., 2001; Du et al., 2018). The gene discussed is NGF; the disease is Alzheimer disease.